Shopping Cart 0
Cart Subtotal
AED 0

Intrexon Corp (XON)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon's UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of network collaborators and joint ventures to commercialize its technologies. Intrexon is headquartered in Germantown, Maryland, the US.

Intrexon Corp (XON)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Intrexon Corp, Medical Equipment, Deal Details 10

Venture Financing 10

Intrexon Secures US$1.1 Million In Venture Financing 10

Immunologix Raises US$0.25 Million In Venture Financing 10

Intrexon Raises US$100 Million In Series E Financing 11

Partnerships 11

OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 11

Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 13

Acquisition 14

Intrexon to Acquire GenVec 14

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 15

Intrexon Corp-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Mar 10, 2017: Intrexon Creates Precigen and Accelerates Strategic Review of Structural Options Related to Health Assets 20

Financial Announcements 21

May 10, 2017: Intrexon Announces First Quarter 2017 Financial Results 21

Mar 01, 2017: Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results 23

Nov 09, 2016: Intrexon Announces Third Quarter 2016 Financial Results 26

Corporate Communications 29

Jun 29, 2017: Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen 29

May 18, 2017: Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec 30

Apr 27, 2017: Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Intrexon Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Intrexon Corp, Medical Equipment, Key Facts, 2016 1

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Deals By Market, 2011 to YTD 2017 8

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Intrexon Secures US$1.1 Million In Venture Financing 10

Immunologix Raises US$0.25 Million In Venture Financing 10

Intrexon Raises US$100 Million In Series E Financing 11

OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 11

Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 13

Intrexon to Acquire GenVec 14

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 15

Intrexon Corp, Key Competitors 17

Intrexon Corp, Key Employees 18

Intrexon Corp, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Intrexon Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon's UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of network collaborators and joint ventures to commercialize its technologies. Intrexon is headquartered in Germantown, Maryland, the US.

Intrexon Corp (XON)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Intrexon Corp, Medical Equipment, Deal Details 10

Venture Financing 10

Intrexon Secures US$1.1 Million In Venture Financing 10

Immunologix Raises US$0.25 Million In Venture Financing 10

Intrexon Raises US$100 Million In Series E Financing 11

Partnerships 11

OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 11

Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 13

Acquisition 14

Intrexon to Acquire GenVec 14

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 15

Intrexon Corp-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Mar 10, 2017: Intrexon Creates Precigen and Accelerates Strategic Review of Structural Options Related to Health Assets 20

Financial Announcements 21

May 10, 2017: Intrexon Announces First Quarter 2017 Financial Results 21

Mar 01, 2017: Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results 23

Nov 09, 2016: Intrexon Announces Third Quarter 2016 Financial Results 26

Corporate Communications 29

Jun 29, 2017: Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen 29

May 18, 2017: Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec 30

Apr 27, 2017: Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Intrexon Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Intrexon Corp, Medical Equipment, Key Facts, 2016 1

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Intrexon Corp, Deals By Market, 2011 to YTD 2017 8

Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Intrexon Secures US$1.1 Million In Venture Financing 10

Immunologix Raises US$0.25 Million In Venture Financing 10

Intrexon Raises US$100 Million In Series E Financing 11

OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 11

Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 13

Intrexon to Acquire GenVec 14

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 15

Intrexon Corp, Key Competitors 17

Intrexon Corp, Key Employees 18

Intrexon Corp, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Intrexon Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.